{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:37:29Z","timestamp":1757540249190},"reference-count":91,"publisher":"Wiley","issue":"S133","license":[{"start":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T00:00:00Z","timestamp":1294704000000},"content-version":"vor","delay-in-days":9506,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Obstet Gynecol Scand"],"published-print":{"date-parts":[[1985,1]]},"abstract":"<jats:p>Most progestogens in oral contraceptives are testosterone derivatives and have androgenic side effects such as weight increase, acne and hirsutism. They pose a problem to many women just like the clinical picture of the polycystic ovary syndrome (PCO) with obesity, hirsutism, acne and amenorrhea.<\/jats:p><jats:p>The aim of this study was to evaluate androgenicity of the most used progestogens with special reference to desogestrel which is a new progestogen.<\/jats:p><jats:p>Radioimmunoassay was used for hormone determination while serum proteins were determined with electroimmunoassay or in some studies for sex hormone binding globulin (SHBG) with capacity assays. Serum lipids and lipoproteins were determined in serum and after ultracentrifugation in HDL, LDL and VLDL fractions.<\/jats:p><jats:p>In a comparative study on levonorgestrel\/ethinylestradiol (EE) (n = 10) versus desogestrel\/ethinylestradiol (n=10) the latter combination gave increases in SHBG capacity while the former did not. Similar increases in estrogen\u2010sensitive proteins Cortisol binding globulin (CBG) and ceruloplasmin indicated that the estrogenicity and \u201cantiestrogenicity\u201d was the same for the two combinations whereas the androgenicity of levonorgestrel was greater giving a reduction in the EE\u2010induced increase in SHBG (SHBG is increased by estrogens and suppressed by androgens). When giving desogestrel 0.125\u20130.500 mg and lynestrenol 5 mg alone in daily doses to a group of regularly menstruating women (n = 8) strong suppression of SHBG was achieved while ceruloplasmin, CBG and thyroxine binding globulin (TBG) did not change. TBG is decreased and prealbumin increased by androgenic\/anabolic activity but only a moderate increase in prealbumin was found during lynestrenol treatment. The changes in SHBG are probably the result of a dose\u2010dependent receptor interaction related to 17a\u2010alkylation in 19\u2010norsteroids.<\/jats:p><jats:p>Twenty women with PCO were treated for 8 months with 0.150 mg desogestrel\/0.030 mg EE. Evaluation was done before treatment and after 3 and 8 \u201cpill\u201d cycles regarding androgens, estradiol, SHBG, hirsutism and body weight. Spontaneous menstrual cycles were assessed after treatment. Serum lipids and lipoproteins were studied before treatment and at the end of the third \u201ccycle\u201d. In PCO the suppression of increased total and free testosterone levels (in comparison to 22 healthy women) was evident during treatment, concordant with increases in SHBG capacity. Hirsutism was suppressed and body weight was reduced in obese women. After treatment three women wishing pregnancy got pregnant and eight others continued menstruating. The other nine had a recurrence of PCO. The only difference in lipids before treatment in the PCO group compared to a group of healthy women (n = 13) were higher levels of triglycerides and VLDL triglycerides. During treatment only a higher VLDL triglyceride level was found in PCO women than in the normal control group. PCO women thus react in the same way as healthy women to desogestrel\/EE treatment. No serious side effects were encountered and no significant changes in libido seen. It can be concluded that desogestrel is a strong progestogen lacking measurable androgenicity. It is a suitable progestogen for use in women with low SHBG capacity who are at risk for androgenic side effects.<\/jats:p>","DOI":"10.3109\/00016348509157028","type":"journal-article","created":{"date-parts":[[2009,12,8]],"date-time":"2009-12-08T17:56:22Z","timestamp":1260294982000},"page":"1-30","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacodynamic Studies on Desogestrel Administered Alone and in Combination with Ethinylestradiol"],"prefix":"10.1111","volume":"64","author":[{"given":"G\u00f6ran","family":"Cullberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,11]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1974.tb03298.x"},{"key":"e_1_2_1_3_1","first-page":"141","volume-title":"The Endocrine Function of the Human Ovary","author":"Andersson D C.","year":"1976"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0002-9378(76)90587-1","article-title":"Response of the binding capacity of plasma testosterone\u2010estradiol\u2010binding globulin to norethindrone and mestranol 0.1 mg in polycystic ovarian disease","volume":"125","author":"Andersson R N.","year":"1976","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-32-2-232"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)46571-4"},{"key":"e_1_2_1_7_1","first-page":"1","article-title":"Ischemic heart disease in women","volume":"549","author":"Bengtsson C.","year":"1973","journal-title":"Acta Med Scand (Suppl)"},{"key":"e_1_2_1_8_1","first-page":"33","article-title":"Binding of contraceptive progestogens to receptor proteins in human myometrium and MCF\u20107 cells","volume":"10","author":"Bergink E W.","year":"1984","journal-title":"Br J Family Planning"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(81)90031-1"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365518109090512"},{"key":"e_1_2_1_11_1","first-page":"76","volume-title":"Distribution\u2010free statistical tests","author":"Bradley J V.","year":"1968"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197807062990104"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(77)90507-0"},{"key":"e_1_2_1_14_1","first-page":"83","volume-title":"Metabolic effects of hormonal contraceptives","author":"Briggs M H.","year":"1980"},{"key":"e_1_2_1_15_1","first-page":"35","article-title":"Effect of oral progestogens on estrogen\u2010induced changes in serum protein","volume":"344","author":"Briggs M.","year":"1974","journal-title":"Excerpta Medica Int Congr Ser"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.1978.tb00574.x"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-29-7-948"},{"key":"e_1_2_1_18_1","article-title":"Changes in serum apolipoprotein AI and sex\u2010hormone binding globulin levels after treatment with two different progestins administered alone and in combination with ethinylestradiol","author":"Crona N.","year":"1983","journal-title":"Diss University of G\u00f6teborg"},{"key":"e_1_2_1_19_1","first-page":"97","article-title":"RestovarR\u2010New low\u2010dose, combined, oral contraceptive. Effects on serum proteins, free testosterone and clinical efficacy","volume":"5","author":"Cullberg G.","year":"1984","journal-title":"Contracept Deliv Syst"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016348209155354"},{"key":"e_1_2_1_21_1","volume-title":"Discordant effects on the concentrations of three plasma proteins by two gestagens in combination with ethinylestradiol","author":"Cullberg G.","year":"1979"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5436.695"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016348209155355"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(82)90072-5"},{"key":"e_1_2_1_25_1","first-page":"55","article-title":"Mood changes and menstrual symptoms with different gestagen\/estrogen combinations. A double blind comparison with a placebo","volume":"236","author":"Cullberg J.","year":"1972","journal-title":"Acta Psychiat Scand (Suppl)"},{"key":"e_1_2_1_26_1","first-page":"689","article-title":"Synthesis and release of gonadotropins: Effect of an oral contraceptive","volume":"62","author":"Dericks\u2010Tan J SE","year":"1983","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1985.tb01061.x"},{"key":"e_1_2_1_28_1","first-page":"106","article-title":"Progestational potency of oral contraceptives","volume":"47","author":"Dickey R P.","year":"1976","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-57-2-304"},{"key":"e_1_2_1_30_1","first-page":"62","article-title":"Plasma high\u2010density lipoprotein cholesterol: Association with measurements of body mass","volume":"62","author":"Glueck C J.","year":"1980","journal-title":"Circulation (Suppl IV)"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)45429-4"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(71)90096-2"},{"key":"e_1_2_1_33_1","first-page":"133","article-title":"Studies on the pattern of circulating steroids in the normal menstrual cycle","volume":"81","author":"Guerero R.","year":"1976","journal-title":"Acta Endocrinol (Copenh)"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)47956-2"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198103053041002"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(79)90036-2"},{"key":"e_1_2_1_37_1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0002-9378(16)37277-5","article-title":"The Stein\u2010Leventhal syndrome. Analysis of 43 cases with special reference to association with endometrial carcinoma","volume":"73","author":"Jackson R L.","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_1_38_1","first-page":"779","article-title":"Depression of the progesterone levels in women treated with synthetic gestagens after ovulation","volume":"68","author":"Johansson E DB","year":"1971","journal-title":"Acta Endocrinol (Copenh)"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-36-3-475"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(75)90050-5"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0420337"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365518409083621"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1980.tb01033.x"},{"key":"e_1_2_1_44_1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0015-0282(16)45318-5","article-title":"Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive","volume":"35","author":"Larsson\u2010Cohn U.","year":"1981","journal-title":"Fertil Steril"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1092755"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365516809077003"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-49-5-719"},{"key":"e_1_2_1_48_1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/clinchem\/27.5.653","article-title":"Cholesterol, apoproteins, and heart disease. Present status and future prospects","volume":"27","author":"Levy R I.","year":"1981","journal-title":"Clin Chem"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(79)90119-X"},{"key":"e_1_2_1_50_1","first-page":"193","volume-title":"Recent Progress in Reproductive Endocrinology","author":"Lindner H R.","year":"1974"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-52-1-156"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-31-5-556"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1979.tb03031.x"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1037266"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1018621"},{"key":"e_1_2_1_56_1","first-page":"246","article-title":"The maturation value","volume":"11","author":"Meisels A.","year":"1967","journal-title":"Acta Cytol"},{"key":"e_1_2_1_57_1","first-page":"601","article-title":"The origin of androgen synthesis in polycystic ovary syndrome","volume":"62","author":"Milewicz A.","year":"1983","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(70)80053-8"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)92274-7"},{"key":"e_1_2_1_60_1","first-page":"585","article-title":"Contraceptive mechanism of microdose norethindrone","volume":"41","author":"Moghissi K S.","year":"1973","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-25-9-1163"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016348409156992"},{"key":"e_1_2_1_63_1","first-page":"248","article-title":"Effects of oestradiol on sex hormone binding globulin","volume":"101","author":"Odlind V.","year":"1982","journal-title":"Acta Endocrinol"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1980.tb04571.x"},{"key":"e_1_2_1_65_1","first-page":"26","article-title":"Oral progesterone and estrogen\u2010progestogen therapy","volume":"127","author":"Ottoson U\u2010B","year":"1984","journal-title":"Acta Obstet Gynecol Scand (Suppl)"},{"key":"e_1_2_1_66_1","first-page":"417","article-title":"Etude clinique, biologique, anatomique de 6 syndromes de Stein\u2010Leventhal de l'adolescence","volume":"38","author":"Petrus M.","year":"1981","journal-title":"Arch Fr Pediatr"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-52-6-1246"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(75)90055-2"},{"key":"e_1_2_1_69_1","first-page":"541","article-title":"Further analyses of mortality in oral contraceptive users","author":"Royal College of General Practitioners' Oral Contraception study","year":"1981","journal-title":"Lancet"},{"key":"e_1_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(76)90031-9"},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(76)90165-5"},{"key":"e_1_2_1_72_1","first-page":"126","article-title":"Efficacy of three phase oral contraceptives. In: International Symposium on Hormonal Contraception. Utrecht 10th Sept 1977","author":"Schneider W HF","year":"1978","journal-title":"Excerpta Medica"},{"key":"e_1_2_1_73_1","first-page":"159","article-title":"The oestrogenic potency of various contraceptive steroids as determined by their effects on transcortin\u2010binding capacity","volume":"76","author":"Schwartz U.","year":"1974","journal-title":"Acta Endrocrinol (Copenh)"},{"key":"e_1_2_1_74_1","first-page":"15","article-title":"Normalization of testosterone levels using a low estrogen containing oral contraceptive in women with polycystic ovary syndrome","volume":"60","author":"Shailaja G R.","year":"1982","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)47903-3"},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(76)90004-4"},{"key":"e_1_2_1_77_1","volume-title":"Clinical Gynecologic Endocrinology & Infertility, Third ed","author":"Speroff L.","year":"1983"},{"key":"e_1_2_1_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-011-6675-1_13"},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(15)30642-6"},{"key":"e_1_2_1_80_1","first-page":"217","article-title":"The significance of alterations in serum lipids in thyroid dysfunction. II. Alterations of the metabolism and turnover of 131I\u2010low density lipoproteins","volume":"29","author":"Walton K W.","year":"1965","journal-title":"Clin Sci"},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(82)90131-7"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-29-11-1470"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(77)90079-8"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-43-1-244"},{"key":"e_1_2_1_85_1","first-page":"321","article-title":"Free testosterone concentration in serum: A method for determination","volume":"130","author":"Wiest W G.","year":"1978","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(78)90061-4"},{"key":"e_1_2_1_87_1","first-page":"405","article-title":"Pharmacological profile of a new orally active progestational steroid, Org 2969","volume":"199","author":"Visser J.","year":"1975","journal-title":"Acta Endocrinol (Suppl) (Copenh)"},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.28.4.326"},{"key":"e_1_2_1_89_1","first-page":"137","article-title":"Evidence for the hypothalamic origin of the polycystic ovary syndrome","volume":"58","author":"Wortsman J.","year":"1981","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_90_1","first-page":"342","article-title":"Abnormalities of fuel metabolism in the polycystic ovary syndrome","volume":"60","author":"Wortsman J.","year":"1982","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1980.tb02132.x"},{"key":"e_1_2_1_92_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016348109154133"}],"container-title":["Acta Obstetricia et Gynecologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.3109%2F00016348509157028","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.3109\/00016348509157028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T20:28:52Z","timestamp":1697833732000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.3109\/00016348509157028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,1]]},"references-count":91,"journal-issue":{"issue":"S133","published-print":{"date-parts":[[1985,1]]}},"alternative-id":["10.3109\/00016348509157028"],"URL":"https:\/\/doi.org\/10.3109\/00016348509157028","archive":["Portico"],"relation":{},"ISSN":["0001-6349","1600-0412"],"issn-type":[{"value":"0001-6349","type":"print"},{"value":"1600-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,1]]},"assertion":[{"value":"2011-01-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}